scholarly journals Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”

2021 ◽  
Vol 2021 ◽  
pp. 1-1
Author(s):  
Tereza Losmanová ◽  
Félice A. Janser ◽  
Magali Humbert ◽  
Igor Tokarchuk ◽  
Anna M. Schläfli ◽  
...  

2020 ◽  
Author(s):  
Henrik Schinke ◽  
Theresa Heider ◽  
Timm Herkommer ◽  
Florian Simon ◽  
Alexandra Blancke Soares ◽  
...  

2016 ◽  
Vol 5 (6) ◽  
pp. 767-772 ◽  
Author(s):  
Masahide Ikeguchi ◽  
Yusuke Kouno ◽  
Kyoichi Kihara ◽  
Kazunori Suzuki ◽  
Kanenori Endo ◽  
...  

Author(s):  
Christina S. Kong ◽  
Balasubramanian Narasimhan ◽  
Hongbin Cao ◽  
Shirley Kwok ◽  
Julianna P. Erickson ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Tereza Losmanová ◽  
Félice A. Janser ◽  
Magali Humbert ◽  
Igor Tokarchuk ◽  
Anna M. Schläfli ◽  
...  

LAMP2A and HSC70 are crucial players in chaperone-mediated autophagy (CMA), a targeted, lysosome-dependent protein degradation pathway. Elevated LAMP2A levels, indicative of increased CMA activity, are observed in several malignancies, and CMA downregulation may be exploited therapeutically. We evaluated the impact of LAMP2A and HSC70 in pulmonary squamous cell carcinomas (pSQCC). Antibodies were validated by knockdown and overexpression experiments using three different cell lines. Expression levels in tissue were analyzed by immunohistochemistry in a cohort of 336 consecutive pSQCC using tissue microarrays. There was no significant correlation between the two markers among each other and no association with pathological parameters (TNM categories, grading). However, both high LAMP2A and HSC70 expression were associated with worse outcome, including overall survival (OS; p=0.012 and p=0.001) and disease free survival (DFS; p=0.049 and p=0.036). In multivariate analysis, both markers and a combination of them were independent adverse prognostic factors for OS (LAMP2Ahigh: HR=2.059; p<0.001; HSC70high: HR=1.987; p<0.001; LAMP2Ahigh/HSC70high: HR=1.529; p<0.001) and DFS (LAMP2Ahigh: HR=1.709; p=0.004; HSC70high: HR=1.484; p=0.027; LAMP2Ahigh/HSC70high: HR=1.342, p<0.001). The negative prognostic impact of high LAMP2A and HSC70 and their variable expression in pSQCC may justify the use of these proteins as potential biomarkers for future CMA-inhibiting therapies.


Author(s):  
Karvita B. Ahluwalia ◽  
Nidhi Sharma

It is common knowledge that apparently similar tumors often show different responses to therapy. This experience has generated the idea that histologically similar tumors could have biologically distinct behaviour. The development of effective therapy therefore, has the explicit challenge of understanding biological behaviour of a tumor. The question is which parameters in a tumor could relate to its biological behaviour ? It is now recognised that the development of malignancy requires an alteration in the program of terminal differentiation in addition to aberrant growth control. In this study therefore, ultrastructural markers that relate to defective terminal differentiation and possibly invasive potential of cells have been identified in human oral leukoplakias, erythroleukoplakias and squamous cell carcinomas of the tongue.


1998 ◽  
Vol 23 (3) ◽  
pp. 268-269
Author(s):  
Liloglou ◽  
Scholes ◽  
Spandidos ◽  
Jones ◽  
Vaughan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document